Tag: Quinazolines

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Quinazolines

Lutris Pharma Phase 1 Results of LUT014 for Skin Toxicities Associated with Treatment of ...

Added to Collection on: 2021-04-28 14:03:45

Tags for this article:

Organic compounds
Chemical compounds
Aromatic compounds
Quinazolines
Bristol-Myers Squibb
Cetuximab
Epidermal growth factor receptor
Chloroarenes
Panitumumab
Gefitinib
KRAS

Click the tags to see associated articles and topics

View Article Details
Dual HER2-Targeted Therapy for MBC

Added to Collection on: 2021-06-29 13:30:00

Tags for this article:

Clinical medicine
Medicine
Health care
Antineoplastic drugs
Cancer treatments
Immunology
Quinazolines
HER2/neu
Trastuzumab
Pertuzumab
Lapatinib
Targeted therapy
Briana Contreras
Ian E. Krop

Click the tags to see associated articles and topics

View Article Details
Progress in Treatment of Non-Small Cell Lung Cancer Harboring HER2 Aberrations

Added to Collection on: 2021-07-06 00:45:00

Tags for this article:

Tyrosine kinase receptors
Organic compounds
Chemical compounds
Branches of biology
Lung cancer
Clusters of differentiation
Oncogenes
Quinazolines
HER2/neu
Afatinib
Adenocarcinoma of the lung
Protein kinase inhibitor
Ann Oncol
Paclitaxel
Trastuzumab
Cisplatin

Click the tags to see associated articles and topics

View Article Details
Cancer biotech ArriVent Biopharma files for a $100 million IPO - Renaissance Capital

Added to Collection on: 2024-01-06 09:46:39

Tags for this article:

Lung cancer
Quinazolines
Oncogenes
Tyrosine kinase receptors
Tyrosine-kinase inhibitor
Antineoplastic drugs
Epidermal growth factor receptor
Non-small-cell lung cancer
Protein kinase inhibitor
Afatinib
T790M

Click the tags to see associated articles and topics

View Article Details
ArriVent BioPharma Reports Full Year 2023 Financial Results - Yahoo Finance

Added to Collection on: 2024-03-28 20:14:00

Tags for this article:

Oncogenes
Lung cancer
Tyrosine kinase receptors
Non-small-cell lung cancer
Epidermal growth factor receptor
Quinazolines
ARRIVENT BIOPHARMA
ArriVent Biopharma Inc.

Click the tags to see associated articles and topics

View Article Details
ArriVent BioPharma Reports Full Year 2023 Financial Results - GlobeNewswire

Added to Collection on: 2024-03-28 20:07:07

Tags for this article:

Oncogenes
Lung cancer
Non-small-cell lung cancer
Epidermal growth factor receptor
Quinazolines
ARRIVENT BIOPHARMA
ArriVent Biopharma Inc.

Click the tags to see associated articles and topics

View Article Details
Tucatinib Plus Trastuzumab Shows "Clinically Meaningful" Activity in HER2+ Metastatic CRC

Added to Collection on: 2024-06-18 16:05:03

Tags for this article:

Cancer treatments
Antineoplastic drugs
Orphan drugs
Quinazolines
Immunology
Tucatinib
Trastuzumab
HER2
Seagen
Trastuzumab emtansine
John H. Strickler

Click the tags to see associated articles and topics

View Article Details
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Receives Marketing Authorization in ...

Added to Collection on: 2024-11-27 23:45:12

Tags for this article:

Antineoplastic drugs
Orphan drugs
Lung cancer
Quinazolines
Antibody-drug conjugate
Biotechnology
Triple-negative breast cancer
Non-small-cell lung cancer
Atezolizumab
Pembrolizumab
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL

Click the tags to see associated articles and topics

View Article Details
Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER ...

Added to Collection on: 2025-04-09 15:03:40

Tags for this article:

Cancer treatments
Antineoplastic drugs
Quinazolines
Clinical pharmacology
Drug safety
Trastuzumab emtansine
HER2
Breast cancer
Lapatinib
Trastuzumab
Adverse effect
Adverse event
Pertuzumab
Neratinib
T-DM1

Click the tags to see associated articles and topics

View Article Details
Pfizer's Latest Study on HER2-positive Breast Cancer: Key Insights for Investors

Added to Collection on: 2025-08-14 16:33:25

Tags for this article:

Antineoplastic drugs
Orphan drugs
Antibody-drug conjugates
Cancer treatments
Quinazolines
Tucatinib
Trastuzumab deruxtecan
HER2
Trastuzumab
Breast cancer
Deruxtecan
Trastuzumab emtansine
Pfizer Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo